Division of Rheumatology
NYU Langone Health’s Division of Rheumatology, part of the Department of Medicine, is one of the leading rheumatology divisions in the country. Under the leadership of Jill P. Buyon, MD, division director, we pursue a tradition of excellence reflected in our tripartite mission of providing outstanding training of clinician–scientists; conducting innovative basic, translational, and clinical research; and offering the latest advances in clinical services.
NYU Langone rheumatologists find that methotrexate impairs the COVID-19 vaccine response.
NYU Langone is part of multi-center research on colchicine, excessive inflammation, and COVID-19.
Important new research findings from NYU Langone rheumatologists evaluate COVID-19 risk in patients with systemic lupus erythematosus.